Subscribe to:
POZ magazine E-newsletters
POZ Personals Sign In / Join
Username:
Password:
African American Hub News
 

Back to home » News & Views » Treatment News


 

November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007


emailrssprint

May 19, 2008

GSK Responds to Accusations About Abacavir

GlaxoSmithKline (GSK) asserts it has been fully forthcoming regarding its drug abacavir (found in Ziagen, Epzicom and Trizivir) and a possible link to heart attacks, according to a letter GSK sent late last week to The Independent. The letter refutes an article published on May 12 suggesting that the company neglected to publicly disclose a Swedish report filed with the company in 2005—three years before the international Data Collection on Adverse Events on Anti-HIV Drugs (D:A:D) study documented a 90 percent increased risk of heart attack among patients taking abacavir.  

When the D:A:D study results initially became public—first at the 15th Conference on Retroviruses and Opportunistic Infections in February in Boston, and then in an April issue of The Lancet—GSK responded by saying that an analysis of their studies on abacavir turned up no sign of an increased risk of a heart attack. The Independent, however, said that GSK failed at that time to mention that physicians in Uppsala, Sweden, sent GSK a warning letter in May 2005 detailing 34 cases of heart attacks in their patients taking the nucleoside reverse transcriptase inhibitor.

In their letter, GSK asserts that they cooperated fully with the Food and Drug Administration (FDA) at the time of the 2005 report and that extensive analysis of multiple databases satisfied both GSK and the FDA that there was no added heart attack risk in people taking abacavir.

NEW! Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team review all comments before they are posted. Please do not include either ":" or "@" in your comment.)

| Posting Rules

Previous Comments:

  comments 1 - 2 (of 2 total)    

Mike, Ridgeland, MS, 2008-05-21 15:58:56
Steve ... thanks for the follow through ... I'm on Epzicom and previous family history as well as my own Cholesterol increase has me concerned as well. I'll be checking a bit further, but as I've discovered in the past, some of these studies and results are skewed.

Steve, , 2008-05-21 11:58:06
I've been taking Trizivir for 5 years now, so was quite concerned about this. But it is VERY important to read further to put studies like this in perspective. After reading the D_A_D study results, this 90% increase is based on the ORIGINAL possibility of an hiv+ person (considering all other risk factors), possibly having a heart attack of 2%, and the 90% increase in THIS study changes THAT risk to 3.8%, which is quite a difference! Knowledge (and further research on one's own) is power.

comments 1 - 2 (of 2 total)    


[Go to top]


Get Answers
What to do if you've just been diagnosed
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

Blogs by African-Americans
Antonia
Felipe
Jeanette
Pinnace
Kate
Ferguson

Read the blogs
Overheard in the Forums
"I'm HIV positive and diabetic (as well as have high cholesterol) and some of my meds specify taking them with 'high fat foods' which I have to do twice a day. I've eaten as healthy as possible, but when it comes to high fat foods, I am in a quandary...about what to eat sometimes..."

from Nutrition & HIV


Join the forums

Real Health Poll
Question: How often do you order combo meals at fast food eateries?
Always
Sometimes
Never

Smart + Strong Network
POZ Magazine
POZ Personals
POZ Mentor
POZ ASO Directory
AIDSmeds
Real Health Magazine
TuSalud Magazine
ComboCards
Rx Info Cards
Also visit POZ on...
Facebook

MySpace

YouTube

[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertise/contact us | site map]
© 2008 Smart + Strong. All Rights Reserved. Terms of use and Your privacy